APA (7th ed.) Citation

de Vries Lentsch, S., Garrelds, I. M., Danser, A. H. J., Terwindt, G. M., & MaassenVanDenBrink, A. (2022). Serum CGRP in migraine patients using erenumab as preventive treatment. Journal of headache and pain, 23(1), 120-7. https://doi.org/10.1186/s10194-022-01483-z

Chicago Style (17th ed.) Citation

de Vries Lentsch, Simone, Ingrid M. Garrelds, A. H. Jan Danser, Gisela M. Terwindt, and Antoinette MaassenVanDenBrink. "Serum CGRP in Migraine Patients Using Erenumab as Preventive Treatment." Journal of Headache and Pain 23, no. 1 (2022): 120-7. https://doi.org/10.1186/s10194-022-01483-z.

MLA (9th ed.) Citation

de Vries Lentsch, Simone, et al. "Serum CGRP in Migraine Patients Using Erenumab as Preventive Treatment." Journal of Headache and Pain, vol. 23, no. 1, 2022, pp. 120-7, https://doi.org/10.1186/s10194-022-01483-z.